Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | PTAFR | P25105 | 1/20 | 0.38 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30368601 | 0.98 | ALDH1A1 (0.42) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL13135372 | 0.96 | ALDH1A1 (0.43) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL20086814 | 0.92 | TDP1 (0.43) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL20086819 | 0.92 | HPRT1 (0.45) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL22079954 | 0.92 | HPRT1 (0.45) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL22079686 | 0.92 | HPRT1 (0.45) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL18801418 | 0.90 | HPRT1 (0.44) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL15150052 | 0.89 | PTPRC (0.37) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL15681405 | 0.88 | CA12 (0.46) | ALDH1A1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL12636524 | 0.87 | NPC1 (0.43) | ALDH1A1TSHRRAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9574084-B2 | Hole transport composition | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-9159927-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-13 | — | — | US | disclosed |
| US-8889269-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| US-8652655-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-02-18 | — | — | US | disclosed |
| US-20130193423-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130150536-A1 | HOLE TRANSPORT COMPOSITION | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | US | disclosed |
| US-8343381-B1 | Hole transport composition | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-01 | — | — | US | disclosed |
| US-20120065432-A1 | ELECTROACTIVE MATERIALS | E.I DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120013245-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-19 | — | — | US | disclosed |
| US-8063399-B2 | Electroactive materials | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-20110095269-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013245-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | ALDH1A1 290/4885TSHR 1671/4885RAB9A 2485/4885 |
| US-20120065432-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | ALDH1A1 290/4885TSHR 1671/4885RAB9A 2485/4885 |
| US-20110095269-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | ALDH1A1 290/4885TSHR 1671/4885RAB9A 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.